Thu.Jun 12, 2025

article thumbnail

Iowa Governor Signs Bill Limiting PBM Practices

Drug Topics

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

545
545
article thumbnail

Lancet study illustrates drug delivery “milestone”

European Pharmaceutical Review

Researchers have developed a once-weekly oral capsule with an innovative delayed drug release mechanism. This development could help certain patients, such as those with schizophrenia , to take their medicines more consistently. As the drug device can be delivered orally , the new pill “represents an important option that can assist with adherence for the many patients who would prefer oral medications versus injectable formulations,” explained Leslie Citrome, a Clinical Professor of psychiatry

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk

Drug Topics

Direct-to-consumer drug sales may undermine patient care and threaten independent pharmacies by reducing access to personalized, comprehensive medication management.

article thumbnail

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -W

article thumbnail

Recruiting and retaining pharmacists: developing an effective flexible working approach

Hospital Pharmacy Europe

The recruitment and retention of clinical and non-clinical staff is a persistent challenge across secondary care services. Noting a concerning vacancy rate, the pharmacy department at East Kent Hospitals University NHS Foundation Trust set about determining the reasons for this and identifying solutions. Pharmacists Alice Lo and Rebecca Morgan discuss the findings of their flexible working survey and the strategies they’ve implemented to maintain a positive working environment and better support

More Trending

article thumbnail

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

How to help patients get ready for summer

The Checkup by Singlecare

When the weather warms up, many people start making plans: booking summer vacations, signing kids up for summer camp, or preparing for international travel. Whether patients are shopping for travel-size products or comparing sunscreens, pharmacists have a valuable opportunity to step in with expert advice on staying healthy and remembering medications while away from home.

article thumbnail

How to Get Pharmacists & Technicians to Actually Apply for Your Open Positions

DiversifyRx

Hiring pharmacists or technicians shouldn’t feel like pulling teeth, but for many independent pharmacy owners, it does. You post your job opening, wait for the flood of qualified candidates, and instead…crickets. Here’s the hard truth: If you’re struggling to attract applicants, the problem might not be the talent pool; it could be your approach.

article thumbnail

Expert: Pharmacists' Critical Role in Multidisciplinary CIDP Care

Pharmacy Times

Amy Duong, PharmD, BCACP, highlights pharmacists' essential responsibilities in chronic inflammatory demyelinating polyneuropathy (CIDP) patient care and immunoglobulin therapy management.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Upgrade digital systems in hospital pharmacy, RPS says as Government spending review boosts NHS

Hospital Pharmacy Europe

The Royal Pharmaceutical Society is calling on the Government to commit to upgrading digital systems in hospital pharmacy as the chancellor Rachel Reeves announces her much-anticipated spending review. The NHS will receive a £29bn real terms funding boost over the next three years, Ms Reeves said. This equates to a 3% increase in annual day-to-day spending from 2023/24 to 2028/29, making the spending £226bn by the end of the period.

article thumbnail

Vutrisiran marks first silencer approved for ATTR-CM

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

FDA 65
article thumbnail

FDA Posts Slate of Seven Warning Letters Following Company Inspections

PharmTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

FDA 59
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Ascend granted certification for quality control testing at Munich facility

Pharmafile

Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification for quality control (QC) testing at its site in Munich, Germany. This will streamline testing and release of adeno-associated (AAV)-based gene therapy. The Munich facility is now permitted to perform advanced commercial assays for DNA […] The post Ascend granted certification for quality control testing at Munich facility appea

59
article thumbnail

Stop Switching Tools: eWizard Launches eVa, the All-in-One AI Agent for Seamless and Compliant Pharma Content

Viseven

Speed and quality are no longer the only benchmarks for pharma and life sciences content creation. In pharma and life sciences, where compliance is a non-negotiable rule and tools often don’t play well together, marketers need more than just AI — they need a solution that connects the dots and respects the rules. That’s exactly the thinking that led us to conceptualize, create, and now release eVa — a new AI agent within the eWizard Content Experience Platform.

article thumbnail

Spring 2025 Quiz: Test Your Pharmacy Knowledge!

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

FDA Approves Mavyret for Treatment of Acute HCV Infection

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

FDA 315
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Do We Really Pay More for Prescription Drugs in the United States?

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection

Drug Topics

This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.

247
247
article thumbnail

How the 340B hospital markup program could hurt Michigan patients

PhRMA

As lawmakers in Lansing debate health care legislation, new evidence reveals a staggering—and deeply troubling—reality: big, tax-exempt hospitals in the state are marking up the price of prescription medicines by nearly $10 billion a year. The federal 340B program is running unchecked with limited transparency and accountability, and comprehensive federal reform is needed to stop abuse of the program.

Hospitals 194
article thumbnail

The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies

Drug Topics

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

247
247
article thumbnail

What Is Smart Pharma Packaging?

Pharmaceutical Commerce

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how it is helping to combat the growing threat of counterfeit drugs in today’s global supply chain.

article thumbnail

Treatment for serious eye disease approved in Scotland

Pharmafile

Outlook Therapeutics has announced the Scottish Medicines Consortium (SMC) approval of Lytenava (bevacizumab gamma) for the treatment of wet age-related macular degeneration (wet AMD). Lytenava is the first and only licensed ophthalmic formulation of bevacizumab for use in treating wet AMD in adults in the EU and UK. The SMC recommendation follows news of Lytenava […] The post Treatment for serious eye disease approved in Scotland appeared first on Pharmafile.

52
article thumbnail

Financial Assistance Programs and Healthcare Plan Navigation

Pharmaceutical Commerce

Amy Niles, chief mission officer, PAN Foundation, provides a deep dive into patient awareness of financial assistance programs, while offering insights into health literacy related to medical plans.

52
article thumbnail

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies

PharmTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

Dosage 52
article thumbnail

Pembrolizumab Receives FDA Approval for Treatment of Head and Neck Squamous Cell Carcinoma

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

FDA 81
article thumbnail

DHL Officially Obtains CRYOPDP

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

52
article thumbnail

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Finerenone and Empagliflozin Outperform Either Treatment Alone in Patients With CKD

Pharmacy Times

Patients with chronic kidney disease (CKD) and type 2 diabetes receiving both treatments had greater reductions in urinary albumin-to-creatinine ratio.

89
article thumbnail

Novartis to Highlight P-IIIb Trial Data of Fabhalta for Paroxysmal Nocturnal Hemoglobinuria (PNH) at EHA 2025

PharmaShots

Shots: Novartis has reported P-IIIb ( APPULSE-PNH ) trial data assessing Fabhalta (iptacopan; 200mg, BID, PO) for 24wks. in 52 PNH adults with Hb levels ≥10g/dL who switched from anti-C5 therapies (eculizumab or ravulizumab) Trial showed a 2.01 g/dL mean Hb increase, with 92.7% pts achieving ≥12g/dL & no transfusions over 24wks. It also depicted improved fatigue per FACIT-Fatigue score (+4.88 at Day 84 & +4.29 at Day 168), along with sustained intravascular hemolysis control & resolv

59
article thumbnail

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Pharmacy Times

New research reveals how individual blood sugar responses to carbohydrates vary, highlighting the importance of personalized dietary approaches for diabetes management.

65